CA
NZ
UK
AU
IND
US
…
Banyan Corp., through its subsidiaries, engages in the franchising of chiropractic clinics in North America. It provides practice development training and assistance to chiropractors, as well as offers franchise support and related services to franchisees and licensees. The company also offers diagnostic testing services. Banyan Corporation provides nerve conduction velocity (NCV) testing to patients through health care professionals, such as doctors and chiropractors. The NCV testing measures the transmission of nerve impulses through the body, identifies problems in the nervous system, and enables to substantiate the cost of treatment to patients and their insurers. In addition, it manufactures and markets the VT3000, a nerve testing system for the diagnosis of neuropathies, which are diseases of the peripheral nerves and parts of the spine, as well as nerve irritation and other damage to the nervous system of a patient. The company was founded in 1978 and is based in Beverly Hills, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 |
| Income before tax | -5.48M | -4.08M | -4.65M | -2.64M | -3.85M |
| Net income | -5.48M | -4.08M | -4.65M | -2.82M | -3.92M |
| Selling general administrative | 7.55M | 6.99M | 2.47M | 2.85M | - |
| Gross profit | 5.00M | 5.45M | 0.99M | 0.36M | 0.66M |
| Ebit | -2.75M | -1.90M | -2.52M | -2.50M | -3.52M |
| Ebitda | - | - | - | - | -3.31M |
| Depreciation and amortization | - | - | - | - | 0.21M |
| Operating income | -2.75M | -1.90M | -2.52M | -2.50M | -3.80M |
| Other operating expenses | - | 0.35M | 0.35M | - | 5.56M |
| Interest expense | 0.00M | 0.00M | 0.00M | 0.00M | 0.12M |
| Income tax expense | 0.00M | 0.00M | 0.00M | 0.00M | 0.12M |
| Total revenue | 5.00M | 5.45M | 1.09M | 0.47M | 1.75M |
| Total operating expenses | 7.76M | 7.35M | 3.61M | 2.96M | 4.47M |
| Cost of revenue | 0.00M | 0.00M | 0.10M | 0.11M | 1.09M |
| Total other income expense net | -2.73M | -2.19M | -2.12M | -0.15M | -0.49M |
| Discontinued operations | - | - | - | -0.17M | - |
| Net income from continuing ops | -5.48M | -4.08M | -4.65M | -2.64M | - |
| Net income applicable to common shares | -5.48M | -4.08M | -4.65M | -2.82M | - |
| Breakdown | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 |
| Total assets | 4.50M | 5.23M | 1.86M | 1.05M | 1.04M |
| Intangible assets | 0.16M | 0.34M | 0.66M | - | - |
| Other current assets | 0.14M | 0.12M | - | - | - |
| Total liab | 4.52M | 4.44M | 2.56M | 2.44M | 2.18M |
| Total stockholder equity | -0.02M | 0.79M | -0.70M | -1.73M | -1.13M |
| Deferred long term liab | 0.02M | 0.08M | 0.16M | - | - |
| Other current liab | 0.32M | 0.47M | 0.59M | 1.22M | 0.42M |
| Common stock | 17.72M | 15.40M | 16.08M | 9.96M | 8.00M |
| Retained earnings | -26.32M | -20.83M | -16.75M | -11.75M | -9.29M |
| Good will | 1.82M | 1.82M | - | - | - |
| Other assets | 0.47M | 0.76M | 0.89M | 0.97M | - |
| Cash | 0.05M | 0.13M | 0.00M | 0.00M | 0.01M |
| Total current liabilities | 2.09M | 2.38M | 1.59M | 2.04M | 1.63M |
| Current deferred revenue | - | - | - | - | 0.27M |
| Net debt | - | - | - | - | 1.24M |
| Short term debt | 0.08M | 3.02M | 0.15M | 0.78M | 0.70M |
| Short long term debt | 0.08M | 3.02M | 0.15M | 0.78M | - |
| Short long term debt total | - | - | - | - | 1.25M |
| Other stockholder equity | -0.01M | -0.03M | -0.03M | 0.05M | - |
| Property plant equipment | 0.06M | 0.09M | - | - | - |
| Total current assets | 1.99M | 2.22M | 0.31M | 0.08M | 0.74M |
| Long term investments | 0.44M | 0.67M | 0.73M | - | - |
| Net tangible assets | -2.00M | -1.37M | -1.36M | -1.73M | - |
| Net receivables | 1.80M | 1.97M | 0.31M | 0.05M | 0.73M |
| Long term debt | 2.40M | 2.00M | 0.97M | 0.40M | - |
| Accounts payable | 0.45M | 0.52M | 0.54M | 0.37M | 0.51M |
| Accumulated other comprehensive income | - | - | - | - | -0.18M |
| Non currrent assets other | - | - | - | - | 0.18M |
| Non current assets total | - | - | - | - | 0.30M |
| Breakdown | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 |
| Investments | 0.28M | 0.06M | 0.02M | - | - |
| Change to liabilities | 0.06M | 0.20M | 0.51M | 0.05M | - |
| Total cashflows from investing activities | 0.25M | -1.77M | -0.68M | -0.68M | -0.00M |
| Net borrowings | 1.48M | 2.70M | 1.66M | 0.36M | - |
| Total cash from financing activities | 1.48M | 2.73M | 1.82M | 1.08M | 0.60M |
| Change to operating activities | -0.02M | -0.07M | 0.02M | 0.02M | - |
| Net income | -5.48M | -4.08M | -4.65M | -2.82M | -3.92M |
| Change in cash | -0.08M | 0.13M | 0.00M | -0.01M | -0.04M |
| Begin period cash flow | - | - | - | - | 0.05M |
| End period cash flow | - | - | - | - | 0.01M |
| Total cash from operating activities | -1.81M | -0.84M | -1.14M | -1.08M | -0.63M |
| Depreciation | 0.27M | 0.49M | 0.18M | 0.02M | 0.21M |
| Other cashflows from investing activities | 0.28M | 0.05M | 0.02M | 0.02M | - |
| Change to account receivables | 0.10M | 0.37M | -0.21M | -0.02M | - |
| Sale purchase of stock | - | 0.03M | 0.16M | 0.88M | - |
| Other cashflows from financing activities | - | - | - | -0.17M | -0.31M |
| Change to netincome | 1.37M | 0.68M | 1.51M | 1.62M | - |
| Capital expenditures | 0.03M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change in working capital | - | - | - | - | 0.32M |
| Other non cash items | - | - | - | - | 2.76M |
| Free cash flow | - | - | - | - | -0.64M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| BNYN Banyan Corp |
- -% |
0.00 | - | - | 0.00 | - | 0.16 | -0.53 |
| HCA HCA Healthcare, Inc. |
-4.89 1.02% |
473.19 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
2.68 0.99% |
273.25 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
0.31 2.36% |
13.35 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
- -% |
5.09 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
Banyan Corp., through its subsidiaries, engages in the franchising of chiropractic clinics in North America. It provides practice development training and assistance to chiropractors, as well as offers franchise support and related services to franchisees and licensees. The company also offers diagnostic testing services. Banyan Corporation provides nerve conduction velocity (NCV) testing to patients through health care professionals, such as doctors and chiropractors. The NCV testing measures the transmission of nerve impulses through the body, identifies problems in the nervous system, and enables to substantiate the cost of treatment to patients and their insurers. In addition, it manufactures and markets the VT3000, a nerve testing system for the diagnosis of neuropathies, which are diseases of the peripheral nerves and parts of the spine, as well as nerve irritation and other damage to the nervous system of a patient. The company was founded in 1978 and is based in Beverly Hills, California.
9025 Wilshire Boulevard, Beverly Hills, CA, United States, 90211
800-808-0899
20
| Name | Title | Year Born |
|---|---|---|
| Mr. Michael J. Gelmon LL.B. | Chairman & CEO | 1965 |
| Mr. Cory H. Gelmon | Pres, COO, CFO, Principal Accounting Officer, Chief Legal Officer, Sec. & Director | 1960 |
| Mr. Cory H. Gelmon | President, COO, CFO, Principal Accounting Officer, Chief Legal Officer, Secretary & Director | 1960 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.82%
Communication Services
-0.22%
Consumer Cyclical
-0.13%
Consumer Defensive
+0.32%
Energy
+0.15%
Financial Services
-0.85%
Financials
+2.34%
Healthcare
-1.28%
Industrials
-0.96%
Real Estate
-0.38%
Technology
-2.73%
Utilities
-0.31%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...